MMP9 and osteosarcoma: After CHE treatment, phosphorylation of PI3K, AKT, and mTOR decreased significantly, indicated that, in CSCs derived from osteosarcoma cells, CHE potentially decreased migration and invasion via inhibiting PI3K/AKT/mTOR pathway and inducing MMP-2, MMP-9 inhibition.